SONX (Sonendo) Capex-to-Revenue: 0.00 (As of Dec. 2024)


SONX Sonendo Inc SONX
47 GF Score
Price $0.60
View Full Analysis

What is Sonendo Capex-to-Revenue?

Sonendo SONX 47 Capex-to-Revenue is 0.00 as of Dec. 2024. GuruFocus rates SONX with a GF Score™ of 47/100.

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Sonendo's Capital Expenditure for the three months ended in Dec. 2024 was $0.00 Mil. Its Revenue for the three months ended in Dec. 2024 was $8.31 Mil.

Hence, Sonendo's Capex-to-Revenue for the three months ended in Dec. 2024 was 0.00.

Sonendo  (OTCPK:SONX) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Sonendo Capex-to-Revenue Related Terms

Sonendo Capex-to-Revenue Historical Data

* Premium members only.

The historical data trend for Sonendo's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonendo Capex-to-Revenue Chart

Sonendo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Revenue
Get a 7-Day Free Trial 0.04 0.06 0.03 0.03 0.01

Sonendo Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.02 0.00 0.00 0.00

SONX vs DHAI, AFIB, ABT: Capex-to-Revenue Comparison

For the Medical Devices subindustry, Sonendo's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sonendo Capex-to-Revenue vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonendo's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sonendo's Capex-to-Revenue falls into.


SONX
47GF Score
Sonendo Inc SONX
Capex-to-Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonendo Capex-to-Revenue Calculation

Sonendo's Capex-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.161) / 31.702
=0.01

Sonendo's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 8.305
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Capex-to-Revenue →
What does a Capex-to-Revenue of 0.00 mean?
Sonendo (SONX) has a Capex-to-Revenue of 0.00 as of Dec. 2024. Capex to Revenue ratio measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. View historical data on Sonendo and its competitors.
Is Sonendo's Capex-to-Revenue too high?
Sonendo's current Capex-to-Revenue is 0.00. Overall, Sonendo has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Sonendo's Capex-to-Revenue compare to DHAI and AFIB?
Sonendo's Capex-to-Revenue of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Revenue for a Medical Devices & Instruments company?
A good Capex-to-Revenue depends on the Medical Devices & Instruments industry context. However, Capex-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Revenue mean?
A high Capex-to-Revenue can signal that a stock is expensive relative to its fundamentals. Capex to Revenue ratio measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. View historical data on Sonendo and its competitors. Sonendo's current Capex-to-Revenue is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonendo stock overvalued right now?
Sonendo (SONX) has a current Capex-to-Revenue of 0.00. The current Capex-to-Revenue is 0.00. Sonendo's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Revenue calculated?
Capex-to-Revenue is calculated from a company's financial statements. For Sonendo (SONX), the current Capex-to-Revenue is 0.00 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sonendo Business Description

Address 26061 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Sonendo Inc is a commercial-stage medical technology company focused on saving teeth from tooth decay, the prevalent chronic disease globally. It has developed the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company operates in two business segments, Product segment which derives key revenue, and Software. Product segment includes sales of the Company's GentleWave System console and related accessories and instruments. Software segment includes sales of the company's traditional software licenses for practice management software to enable an integrated digital office for endodontists.
47GF Score

Get the complete analysis for SONX

Capex-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price